A Phase 1 Study of AC220 (ASP2689) as Maintenance Therap

  • Ustun, Celalettin (PI)

Project: Research project

Project Details

Description

A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant
StatusFinished
Effective start/end date4/1/129/30/17

Funding

  • Astellas Pharma US, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.